Personalis, Inc. [PSNL] - / Tempus AI, Inc. merger
On July 20, 2026, Personalis, Inc. entered into a definitive merger agreement with Tempus AI, Inc., involving a two-step merger process where Personalis will become a wholly-owned subsidiary of Tempus.
Why this matters
Personalis, Inc., a Delaware-incorporated company operating in the medical laboratories sector, has entered into a definitive merger agreement with Tempus AI, Inc. This transaction, announced on July 20, 2026, involves a two-step merger process where Personalis will become a wholly-owned subsidiary of Tempus. The merger consideration for Personalis stockholders includes shares of Tempus Class A Common Stock, calculated based on an exchange ratio, with an option for Tempus to pay cash for up to 50% of the outstanding shares at $16.25 per share. The merger agreement has been recommended by the Personalis Board of Directors to its stockholders for adoption, subject to the terms and conditions outlined in the agreement.